Compare MDT & PSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDT | PSX |
|---|---|---|
| Founded | 1949 | 1875 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.0B | 97.4B |
| IPO Year | 2014 | 2011 |
| Metric | MDT | PSX |
|---|---|---|
| Price | $92.88 | $254.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 19 |
| Target Price | $108.21 | ★ $165.63 |
| AVG Volume (30 Days) | ★ 7.0M | 2.5M |
| Earning Date | 06-03-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.58% | 2.93% |
| EPS Growth | 3.32 | ★ 116.23 |
| EPS | 3.73 | ★ 10.05 |
| Revenue | $36,364,000,000.00 | ★ $132,376,000,000.00 |
| Revenue This Year | $8.91 | $15.71 |
| Revenue Next Year | $6.54 | N/A |
| P/E Ratio | ★ $24.82 | $25.42 |
| Revenue Growth | ★ 8.43 | N/A |
| 52 Week Low | $73.31 | $126.83 |
| 52 Week High | $106.33 | $260.68 |
| Indicator | MDT | PSX |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 77.20 |
| Support Level | $85.35 | $233.55 |
| Resistance Level | $94.72 | N/A |
| Average True Range (ATR) | 2.14 | 6.58 |
| MACD | -0.26 | 0.54 |
| Stochastic Oscillator | 50.91 | 86.27 |
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.